L Gui
Overview
Explore the profile of L Gui including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
83
Citations
498
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Qin Y, Xie J, Wang Y, Liu X, Chen L, He X, et al.
Zhonghua Yi Xue Za Zhi
. 2024 Dec;
104(48):4422-4426.
PMID: 39690539
Exploring the clinical and pathological characteristics and prognostic factors of diffuse large B-cell lymphoma (DLBCL) patients with TP53 mutation. Data of 86 DLBCL patients with TP53 mutation treated with R-CHOP...
2.
Zhang X, Shi P, Gui L, Li Z, Liu S, He X, et al.
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi
. 2024 Sep;
59(9):950-953.
PMID: 39289965
No abstract available.
3.
Ji L, Peng P, Gui L, Yuan P, Qian W, Wang Y, et al.
Gastro Hep Adv
. 2024 Aug;
1(1):79-82.
PMID: 39129936
No abstract available.
4.
Gui L, He X, Zhu Y, Zhang Y, Tang L, Yao J
Clin Oncol (R Coll Radiol)
. 2024 Apr;
36(7):e171-e181.
PMID: 38664176
Aim: Epidemiological evidence on myoepithelial carcinoma is rare. This study aimed to investigate the effect of tumor primary site and treatment modality on survival in patients with head and neck...
5.
Wang K, Zhang W, Gui L, He X, Wang J, Lu H, et al.
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi
. 2024 Apr;
59(4):343-349.
PMID: 38599640
To explore the efficacy and safety of immunoneoadjuvant therapy with pembrolizumab combined with chemotherapy in locally advanced resectable hypopharyngeal squamous cell carcinoma patients. This study was a prospective, single arm,...
6.
Chen X, Xie Z, Lu H, Yang J, Gui L
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi
. 2024 Apr;
59(4):321-328.
PMID: 38599639
To evaluate the efficacy and safety of pembrolizumab plus nab-paclitaxel and platinum as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (R/M HNSCC). This was...
7.
Song Y, Gui L, Liu S
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi
. 2024 Feb;
59(2):187-191.
PMID: 38310370
No abstract available.
8.
Pan Z, Li S, Wang Y, Liu H, Gui L, Dong B
Nan Fang Yi Ke Da Xue Xue Bao
. 2023 Jul;
43(6):906-914.
PMID: 37439162
Objective: To assess the effect of tumor cell lysate (TCL) with low high-mobility group B1 (HMGB1) content for enhancing immune responses of dendritic cells (DCs) against lung cancer. Methods: TCLs...
9.
Diao Y, Wu Z, Chen Z, Gui L, Miao Y, Lan Y, et al.
Zhonghua Yi Xue Za Zhi
. 2022 Nov;
102(43):3469-3475.
PMID: 36396364
To explore the mechanism of nerve growth factor (NGF) in the skeletal muscle fiber remodeling in ischemic limbs during therapeutic angiogenesis. Eighteen female mice with SPF grade, 6 weeks old...
10.
Wu P, Tian Y, Chen G, Wang B, Gui L, Xi L, et al.
Cell Death Differ
. 2021 Jul;
29(6):1299.
PMID: 34331026
No abstract available.